ZYX and breast carcinoma: DST serves as a candidate tumor suppressor and potential biomarker in breast cancer, maintaining focal adhesion integrity, and promoting cell spreading and cell-matrix adhesion while preventing Zyxin accumulation, stabilizing LATS, and restricting YAP activation.34